Stock in Genentech, David Goeddel
Interviewee: David Goeddel. In 1980, Genentech became the first publicly traded biotech company. David Goeddel talks about his investment. (DNAi Location: Manipulation > Production > Players > David Goeddel > Shares and options)
When I joined Genentech my job offer had in it, I could purchase five hundred shares of stock at a dollar a share, I believe it was, and that would cost five hundred dollars. And I asked Swanson can I just join the company and get my salary, I don't want to pay for something, I need the money. And he said believe me, some day you'll be glad you bought this stock and we'll loan you the money, Genentech will loan you the money to purchase it. And I didn't think much more about the stock, then when we're starting to go public we had a few employee meetings and Bob Swanson explained to the employees what it meant, what we were going to do, we were going to raise money and then it would be a publicly traded stock. And rumors started coming around about what the price might be, and then scientists who could do, you know, multiplication on the number of the shares they had by the price, were thinking wow, this, this could be pretty exciting.
robert swanson,bob swanson,dnai,genentech,employee meetings,biotech company,job offer,interviewee,multiplication,insulin,manipulation,salary,biotechnology,scientists,stock,money,david goeddel
Herb Boyer talks about the fateful meeting, which led to the establishment of the first biotech company.
Herb Boyer talks about how the first biotech company got its name.
David Goeddel was one of the first scientists Herb Boyer hired for the insulin project. Here, David Goeddel talks about Genentech's general strategy for synthesizing insulin.
Tour of Genentech by David Ebersman
Herb Boyer talks about his and Bob Swanson's vision on combining the best of academia, industry and business.
David Goeddel talks about what it was like to work at Genetech during its early days.
David Goeddel talks about how another group was trying to make insulin.
David Goeddel talks about the strategy Genentech used in making synthetic insulin.
Genentech, the first biotechnology company, established in 1976.
Herb Boyer and Stan Cohen "invented" recombinant DNA technology.